Euronav NV (NYSE:CMBT – Get Free Report) saw a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 230,300 shares, a growth of 8.5% from the August 31st total of 212,200 shares. Approximately 1.5% of the shares of the stock are short sold. Based on an average trading volume of 159,400 shares, the short-interest ratio is presently 1.4 days.
Euronav Price Performance
Euronav stock traded up $0.20 during mid-day trading on Tuesday, hitting $16.82. The company’s stock had a trading volume of 138,176 shares, compared to its average volume of 674,189. The business has a 50 day moving average of $16.40. Euronav has a 12 month low of $14.10 and a 12 month high of $21.26. The stock has a market cap of $3.39 billion, a PE ratio of 7.45 and a beta of -0.08. The company has a current ratio of 1.37, a quick ratio of 1.32 and a debt-to-equity ratio of 1.54.
Euronav (NYSE:CMBT – Get Free Report) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.22. The company had revenue of $233.66 million for the quarter. Euronav had a net margin of 112.38% and a return on equity of 22.35%. On average, equities research analysts expect that Euronav will post 1.46 earnings per share for the current fiscal year.
Euronav Announces Dividend
Euronav Company Profile
Euronav NV, together with its subsidiaries, engages in the transportation and storage of crude oil worldwide. The company offers floating, storage, and offloading (FSO) services. It also owns and operates a fleet of vessels. The company was incorporated in 2003 and is headquartered in Antwerp, Belgium.
See Also
- Five stocks we like better than Euronav
- 3 Healthcare Dividend Stocks to Buy
- Why Lennar Stock Could Be the Best Play in the Housing Market
- There Are Different Types of Stock To Invest In
- 2 Energy Stocks Fueling the AI Datacenter Boom
- P/E Ratio Calculation: How to Assess Stocks
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Euronav Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Euronav and related companies with MarketBeat.com's FREE daily email newsletter.